Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy-Reference-Cited by-同舟云学术

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy

Published:2002 Issue:1 Volume:16 Page:1-4
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J. Clin. Lab. Anal.

Author:

Tashiro Kyouichi,Koyanagi Ichiro,Saitoh Akemi,Shimizu Ayumi,Shike Toshihide,Ishiguro Chizuru,Koizumi Michiko,Funabiki Kazuhiko,Horikoshi Satoshi,Shirato Isao,Tomino Yasuhiko

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference24 articles.

1. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis

2. Monocyte chemoattractant protein-1 levels in patients with glomerular disease

3. Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy

4. lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minireview: Understanding and targeting inflammatory, hemodynamic and injury markers for cardiorenal protection in type 1 diabetes;Metabolism;2024-04

2. Role of novel biomarker monocyte chemo-attractant protein-1 in early diagnosis & predicting progression of diabetic kidney disease: A comprehensive review;Journal of the National Medical Association;2024-02

3. Macrophage Polarization and Signaling in Diabetic Kidney Disease: A Catalyst for Disease Progression;American Journal of Physiology-Renal Physiology;2023-12-28

4. SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy;Drug Discovery Today;2023-10

5. The therapeutic potential of an allosteric non‐competitive CXCR1/2 antagonist for diabetic nephropathy;Diabetes/Metabolism Research and Reviews;2023-07-20